Vascular endothelial growth factor-A level in human breast milk after intravitreal injection of ranibizumab: a case report
Abstract Background Ranibizumab is one of intravitreal anti-vascular endothelial growth factor agents. It is applied in the treatments of choroidal neovascularization, age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion. Preliminary evidenc...
Saved in:
Main Authors: | Ying Huang (Author), Rong Zhou (Author), Zuhua Sun (Author), Yihan Zheng (Author), Bing Lin (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2022-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Severe hypotony and filtering bleb leak after intravitreal injection of ranibizumab
by: Ilias Georgalas, et al.
Published: (2008) -
Intravitreal long-term sustained ranibizumab delivery using injectable microgel-embedded hydrogel
by: Simin Lee, et al.
Published: (2024) -
Evaluation of intravitreal ranibizumab injection as a line of treatment for chronic central serous retinopathy
by: Emad A.A Saliem
Published: (2019) -
Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders
by: Abraham Hang, et al.
Published: (2023) -
Clinical effects and safety of treating diabetic macular edema with intravitreal injection of ranibizumab combined with retinal photocoagulation
by: Yan PS, et al.
Published: (2016)